• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉疾病的遗传易感性:从希望到进展。

Genetic susceptibility to coronary artery disease: from promise to progress.

作者信息

Watkins Hugh, Farrall Martin

机构信息

Department of Cardiovascular Medicine and Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 9DU, UK.

出版信息

Nat Rev Genet. 2006 Mar;7(3):163-73. doi: 10.1038/nrg1805.

DOI:10.1038/nrg1805
PMID:16462853
Abstract

Family history is an important independent risk factor for coronary artery disease (CAD), and identification of susceptibility genes for this common, complex disease is a vital goal. Although there has been considerable success in identifying genetic variants that influence well-known risk factors, such as cholesterol levels, progress in unearthing novel CAD genes has been slow. However, advances are now being made through the application of large-scale, systematic, genome-wide approaches. Recent findings particularly highlight the link between CAD and inflammation and immunity, and highlight the biological insights to be gained from a genetic understanding of the world's biggest killer.

摘要

家族病史是冠状动脉疾病(CAD)的一个重要独立风险因素,识别这种常见复杂疾病的易感基因是一个至关重要的目标。尽管在识别影响诸如胆固醇水平等知名风险因素的基因变异方面已经取得了相当大的成功,但在挖掘新的CAD基因方面进展缓慢。然而,现在通过应用大规模、系统性的全基因组方法正在取得进展。最近的研究结果特别强调了CAD与炎症和免疫之间的联系,并突出了从对全球最大杀手的基因理解中获得的生物学见解。

相似文献

1
Genetic susceptibility to coronary artery disease: from promise to progress.冠状动脉疾病的遗传易感性:从希望到进展。
Nat Rev Genet. 2006 Mar;7(3):163-73. doi: 10.1038/nrg1805.
2
A customized genetic approach to the number one killer: coronary artery disease.针对头号杀手——冠状动脉疾病的定制化基因疗法。
Curr Opin Cardiol. 2008 Nov;23(6):629-33. doi: 10.1097/HCO.0b013e32830e6b4e.
3
Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism.确定冠状动脉疾病的易感基因:从夸张到怀疑再到谨慎乐观。
J Intern Med. 2008 May;263(5):538-52. doi: 10.1111/j.1365-2796.2008.01958.x.
4
What will whole genome searches for susceptibility genes for common complex disease offer to clinical practice?全基因组搜索常见复杂疾病的易感基因能为临床实践带来什么?
J Intern Med. 2008 Jan;263(1):16-27. doi: 10.1111/j.1365-2796.2007.01895.x.
5
Translating genomic analyses into improved management of coronary artery disease.将基因组分析转化为冠状动脉疾病的优化管理。
Future Cardiol. 2010 Jul;6(4):507-21. doi: 10.2217/fca.10.28.
6
Predictive genetic testing for coronary artery disease.冠状动脉疾病的预测性基因检测。
Crit Rev Clin Lab Sci. 2009;46(5-6):343-60. doi: 10.3109/07388550903422075.
7
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin.抑郁症状和冠状动脉疾病的共同遗传易感性:与炎症和血清素相关的候选基因综述及进展
Psychosom Med. 2006 Mar-Apr;68(2):187-200. doi: 10.1097/01.psy.0000208630.79271.a0.
8
Genetics of myocardial infarction: a progress report.心肌梗死的遗传学:进展报告。
Eur Heart J. 2010 Apr;31(8):918-25. doi: 10.1093/eurheartj/ehq038. Epub 2010 Mar 10.
9
Future use of genomics in coronary artery disease.基因组学在冠状动脉疾病中的未来应用。
J Am Coll Cardiol. 2007 Nov 13;50(20):1933-40. doi: 10.1016/j.jacc.2007.07.062. Epub 2007 Oct 29.
10
Gene polymorphisms and susceptibility to coronary artery disease.基因多态性与冠状动脉疾病易感性
Pediatr Blood Cancer. 2007 Jun 15;48(7):738-41. doi: 10.1002/pbc.21110.

引用本文的文献

1
A cross-tissue transcriptome-wide association study identifies WDPCP as a potential susceptibility gene for coronary atherosclerosis.一项跨组织全转录组关联研究确定WDPCP是冠状动脉粥样硬化的潜在易感基因。
Atheroscler Plus. 2024 Nov 23;58:59-74. doi: 10.1016/j.athplu.2024.11.002. eCollection 2024 Dec.
2
Epigenetic DNA Methylation and Protein Homocysteinylation: Key Players in Hypertensive Renovascular Damage.表观遗传 DNA 甲基化和蛋白质同型半胱氨酸化:高血压性肾血管损伤的关键因素。
Int J Mol Sci. 2024 Oct 29;25(21):11599. doi: 10.3390/ijms252111599.
3
Mitochondrial related variants associated with cardiovascular traits.
与心血管特征相关的线粒体相关变异体。
Front Physiol. 2024 Aug 27;15:1395371. doi: 10.3389/fphys.2024.1395371. eCollection 2024.
4
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.日本动脉粥样硬化协会(JAS)2022年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2024 Jun 1;31(6):641-853. doi: 10.5551/jat.GL2022. Epub 2023 Dec 19.
5
Gene Regulatory Networks in Coronary Artery Disease.冠状动脉疾病中的基因调控网络。
Curr Atheroscler Rep. 2023 Dec;25(12):1013-1023. doi: 10.1007/s11883-023-01170-7. Epub 2023 Nov 27.
6
Identification of potentially common loci between childhood obesity and coronary artery disease using pleiotropic approaches.利用多效性方法鉴定儿童肥胖症与冠状动脉疾病之间潜在的共同基因座。
Sci Rep. 2022 Nov 14;12(1):19513. doi: 10.1038/s41598-022-24009-8.
7
Tenascin-C as a noninvasive biomarker of coronary artery disease.Tenascin-C 作为冠状动脉疾病的一种非侵入性生物标志物。
Mol Biol Rep. 2022 Oct;49(10):9267-9273. doi: 10.1007/s11033-022-07760-z. Epub 2022 Aug 8.
8
The Spectrum of B Cell Functions in Atherosclerotic Cardiovascular Disease.动脉粥样硬化性心血管疾病中B细胞功能的谱系
Front Cardiovasc Med. 2022 Apr 15;9:864602. doi: 10.3389/fcvm.2022.864602. eCollection 2022.
9
Are risk factors necessary for pretest probability assessment of coronary artery disease? A patient similarity network analysis of the PROMISE trial.是否需要危险因素来评估冠心病的术前概率?来自 PROMISE 试验的患者相似网络分析。
J Cardiovasc Comput Tomogr. 2022 Sep-Oct;16(5):397-403. doi: 10.1016/j.jcct.2022.03.006. Epub 2022 Mar 26.
10
Role of endothelial colony forming cells (ECFCs) Tetrahydrobiopterin (BH4) in determining ECFCs functionality in coronary artery disease (CAD) patients.内皮祖细胞(ECFCs)四氢生物蝶呤(BH4)在决定冠心病(CAD)患者中 ECFCs 功能中的作用。
Sci Rep. 2022 Feb 23;12(1):3076. doi: 10.1038/s41598-022-06758-8.